Adirondack Trust CO Exact Sciences Corp Transaction History
Adirondack Trust CO
- $244 Million
- Q2 2024
A detailed history of Adirondack Trust CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Adirondack Trust CO holds 225 shares of EXAS stock, worth $10,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
225
Previous 228
1.32%
Holding current value
$10,532
Previous $15,000
40.0%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
697Shares Held
160MCall Options Held
5.81MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$830 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA13MShares$610 Million0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$580 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$533 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$500 Million0.13% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.28B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...